U.S. Diabetes Care Devices Market size to cross USD 61.4 Billion by 2034

Selbyville, DE. - U.S. diabetes care devices market was estimated at USD 19.3 billion in 2024 and is expected to grow from USD 21.4 billion in 2025 to USD 61.4 billion by 2034, at a CAGR of 12.4%, according to the latest report published by Global Market Insights Inc.

The widespread incidence of diabetes, combined with a growing aging population and the rise in sedentary lifestyles, is creating an urgent need for effective management tools. As individuals with diabetes require consistent monitoring and control of their blood glucose levels to prevent complications such as heart disease, kidney failure, and nerve damage, the demand for advanced diabetes care devices continues to surge.

Key Insights:

• Market Size & Growth: 
• 2024 Market Size: USD 19.3 billion
• 2025 Market Size: USD 21.4 billion
• 2034 Forecast Market Size: USD 61.4 billion
• CAGR (2025–2034): 12.4%
  

Key Growth Drivers:

1. Technological advancements in diabetes management: Advancements in diabetes care technologies are enhancing the effectiveness and ease of managing the condition.
   
2. Increased awareness and education on diabetes management: As awareness about the importance of managing diabetes effectively grows, patients are becoming more proactive in using diabetes care devices.
   
3. Shift toward personalized and remote diabetes monitoring: The increasing adoption of personalized and remote monitoring devices is transforming how diabetes is managed.
   
4. Favorable government policies and insurance reimbursement: Government policies and reimbursement structures are making diabetes care devices more accessible.
   
5. Aging population and growing healthcare expenditure: The aging population in the U.S. is contributing to the growing demand for diabetes care devices, as the risk of diabetes increases with age.
   

Key Players:

• Abbott Laboratories led the market with over 15.6% share in 2024.
  
• Some of the top players in this market include Abbott Laboratories, Dexcom, F. Hoffmann-La Roche, Ascensia Diabetes Care Holdings, and LifeScan, which together held a 39% share in 2024.
  

Key Challenges

1. High cost of diabetes care devices: The cost of advanced diabetes care devices such as continuous glucose monitors (CGMs), insulin pumps, and smart glucose meters can be prohibitively expensive for many patients, especially those without comprehensive insurance coverage.
   
2. Regulatory and approval delays: The regulatory approval process for new diabetes care technologies can be lengthy and complex.
   
3. Technological complexity and adoption: While diabetes care devices are becoming more sophisticated, many patients, especially older adults, struggle with the technological complexity of new devices.
   
4. Insurance coverage and reimbursement issues: Despite the increasing demand for diabetes care devices, insurance coverage for these devices is inconsistent.
   
5. Data privacy and security concerns: As more diabetes care devices integrate with smartphones, cloud-based platforms, and other digital health technologies, the risk of data breaches and privacy violations increases.
   
6. Limited accessibility in rural and underserved areas: In rural and underserved regions of the U.S., access to diabetes care devices and healthcare professionals who can provide adequate support is often limited.

Browse key industry insights spread across 68 pages with 61 market data tables and figures from the report, “U.S. Diabetes Care Devices Market Size - By Product, By End Use, Growth Forecast, 2025 - 2034” in detail, along with the table of contents:

https://www.gminsights.com/industry-analysis/us-diabetes-care-devices-market

Rising Adoption of Devices

The devices segment held a notable share in 2024, encompassing blood glucose meters, test strips, insulin pens, insulin pumps, and continuous glucose monitoring (CGM) systems. Companies are responding by introducing localized, cost-effective devices with smart features such as Bluetooth connectivity and mobile app integration. To strengthen their foothold, leading players are forming partnerships with local distributors, expanding regional manufacturing, and customizing product lines to meet cultural and economic preferences in urban and rural markets alike.

Homecare to Gain Traction

The home care segment in the U.S. diabetes care devices market generated a significant share in 2024 as more patients shifted toward self-management and at-home monitoring. Factors such as the rising cost of in-clinic care, growing health consciousness, and the increasing prevalence of type 2 diabetes among middle-aged adults have all contributed to this trend. Companies are prioritizing ease of use, portability, and affordability while ensuring accuracy and reliability. Key strategies to capture this segment include launching direct-to-consumer online platforms, offering multilingual user support, and partnering with digital health apps to deliver personalized insights and remote monitoring capabilities.

Major players in the U.S. diabetes care devices market are Abbott Laboratories, Sinocare, Medtronic, Tandem Diabetes Care, Bionime, Dexcom, Eli Lilly and Company, F. Hoffmann-La Roche, LifeScan, Becton, Dickinson and Company, DarioHealth, Ypsomed Holding, Insulet, Nova Biomedical, Novo Nordisk, Ascensia Diabetes Care, Dr. Reddy’s Laboratories, ARKRAY, and B. Braun Melsungen.

Leading companies in the diabetes care devices market are heavily investing in research and development (R&D) to create innovative products that offer better accuracy, convenience, and integration with digital health tools. For instance, companies like Abbott Laboratories and Dexcom have introduced advanced continuous glucose monitoring (CGM) systems with real-time data syncing, enabling patients and healthcare providers to make more informed decisions. These advancements aim to improve patient outcomes and drive long-term market growth. Many companies are forming strategic partnerships with healthcare providers, technology companies, and insurance firms to expand their reach and access to new customer segments.